{"product_id":"proteomics-market-by-product-spectroscopy-chromatography-electrophoresis-x-ray-crystallography-reagent-service-core-proteomics-bioinformatics-application-diagnostic-drug-discovery-end-user-hospital-labs-biopharma-global-forecasts-to","title":"Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecasts to","description":"\u003cp\u003eProteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecasts to 2028\u003c\/p\u003e\n\n\u003cp\u003eThe global proteomics market size is projected to reach USD 72.9 billion by 2028 from 36.8 billion in 2023, at a CAGR of 14.6% during the forecast period. Factors such as increasing government funding for R\u0026amp;D projects to develop new therapeutics and protein-based drugs and the growing demand for personalized and efficient therapeutics, support the demand for proteomics products \u0026amp; services, and drive the market growth at a faster pace.\u003c\/p\u003e\n\n\u003cp\u003e“The spectroscopy segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”\u003c\/p\u003e\n\n\u003cp\u003eOn the basis of instrumentation technologies, the proteomics market is broadly segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to the factor that the technique is widely employed in protein analysis to elucidate the protein structure (size, shape, secondary, or tertiary conformations), quantification, and interactions with molecules such as ligands, solutes, or other proteins.\u003c\/p\u003e \n\n\u003cp\u003e“The biochips sub-segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”\u003c\/p\u003e\n\n\u003cp\u003eOn the basis of instrumentation technology protein microarray, the proteomics market is broadly segmented into biochips and microarray instruments. The biochips segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to the several advantages in proteomics research, including high-throughput analysis, multiplexing, sensitivity, specificity, reduced sample requirements, and automation.\u003c\/p\u003e \n\n\u003cp\u003e“The pharmaceutical \u0026amp; biotechnological companies segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”\u003c\/p\u003e\n\n\u003cp\u003eBased on end users, the proteomics market is segmented into hospitals, clinical laboratories, pharmaceutical companies, academic research laboratories, and other end users like CDMOs, and CROs. The pharmaceutical \u0026amp; biotechnological companies segment held a dominant share of the proteomics market, in 2022. The large share of this segment is attributed to the growing focus of pharma giants on core activities like increasing R\u0026amp;D for the discovery \u0026amp; development of new molecules. This is one of the major factors anticipated to project market growth.\u003c\/p\u003e \n\n\u003cp\u003e“Asia Pacific region is likely to grow at a faster pace.”\u003c\/p\u003e\n\n\u003cp\u003eThe proteomics market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East \u0026amp; Africa. In 2022, North America accounted for the dominant share of the proteomics market. The dominance of the region is attributable to various factors such as the presence of leading players in the region coupled with the ongoing research activities of developing new targeted therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing awareness of personalized therapeutics, rising government initiatives for generic medicines in the region, and the emergence of new market players in the proteomics market.\u003c\/p\u003e \n\n\u003cp\u003eThe primary interviews conducted for this report can be categorized as follows:\u003c\/p\u003e\n\n\u003cp\u003eBy Respondent: Supply Side- 70%, and Demand Side - 30%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation (Supply Side): Managers - 45%, CXOs \u0026amp; Directors - 30%, Executives- 25%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%\u003c\/p\u003e\n\n\u003cp\u003eLists of Companies Profiled in the Report:\u003c\/p\u003e\n\n\u003cp\u003eThermo Fisher Scientific, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eAgilent Technologies, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eMerck KGaA (Germany)\u003c\/p\u003e\n\n\u003cp\u003eDanaher Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eWaters Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eBio-Rad Laboratories, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eBruker Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003ePerkinElmer Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eShimadzu Corporation (Japan)\u003c\/p\u003e\n\n\u003cp\u003eIllumina, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003ePromega Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eEurofins Scientific (Luxembourg)\u003c\/p\u003e\n\n\u003cp\u003eQIAGEN N.V. (Germany)\u003c\/p\u003e\n\n\u003cp\u003eCharles River Laboratories (US)\u003c\/p\u003e\n\n\u003cp\u003eProtagene Protein Services (Germany)\u003c\/p\u003e\n\n\u003cp\u003eCreative Proteomics (US)\u003c\/p\u003e\n\n\u003cp\u003eHORIBA Corporation (Japan)\u003c\/p\u003e\n\n\u003cp\u003eSengenics (Singapore)\u003c\/p\u003e\n\n\u003cp\u003eBiomax Informatics AG (Germany)\u003c\/p\u003e\n\n\u003cp\u003eWuXi NextCode (China)\u003c\/p\u003e\n\n\u003cp\u003eFIOS Genomics (UK)\u003c\/p\u003e\n\n\u003cp\u003eGenewiz (US)\u003c\/p\u003e\n\n\u003cp\u003eMedgenome Labs (India)\u003c\/p\u003e\n\n\u003cp\u003eBiognosys AG (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eMacrogen Inc. (South Korea)\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a detailed picture of the proteomics market. It aims at estimating the size and future growth potential of the market across different segments, such as instrumentation technologies, reagents, software \u0026amp; services, application, end user, and regions. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.\u003c\/p\u003e\n\n\u003cp\u003eKey Benefits of Buying the Report:\u003c\/p\u003e\n\n\u003cp\u003eThe report will help market leaders\/new entrants by providing them with the closest approximations of the revenue numbers for the overall proteomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.\u003c\/p\u003e\n\n\u003cp\u003eThe report provides insights on the following pointers:\u003c\/p\u003e \n\n\u003cp\u003eAnalysis of key drivers (Increasing demand for personalized medicines for clinical practices, Rising incidences of chronic diseases among geriatric population, Increased investments in research and greater adoption of proteomics in drug discovery, Technological advancements in proteomics), restraints (High costs of proteomics instruments and technologies, Lack of standardization in proteomics workflow among research groups), opportunities (High growth opportunities for proteomics research in emerging countries, Growing prominence of nano proteomics in biological processes), and challenges (Low biomarker discovery to approval ratio in proteomics research, Lack of data management\/handling in proteomics research) influencing the growth of proteomics market.\u003c\/p\u003e\n\n\u003cp\u003eProduct \u0026amp; Service Development\/Innovation: Detailed insights on newly launched products, and technological assessment of the proteomics market.\u003c\/p\u003e\n\n\u003cp\u003eMarket Development: Comprehensive information about lucrative markets – the report analyses the proteomics market across varied regions.\u003c\/p\u003e \n\n\u003cp\u003eMarket Diversification: Exhaustive information about new products \u0026amp; services, untapped geographies, recent developments, and investments in the proteomics market.\u003c\/p\u003e \n\n\u003cp\u003eCompetitive Assessment: In-depth assessment of market shares, growth strategies, and product \u0026amp; service offerings of leading players like Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) and among others in the proteomics market.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 578 Pages \/ MCW16230255","offer_id":47647061147954,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/proteomics-market-by-product-spectroscopy-chromatography-electrophoresis-x-ray-crystallography-reagent-service-core-proteomics-bioinformatics-application-diagnostic-drug-discovery-end-user-hospital-labs-biopharma-global-forecasts-to","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}